Cargando…
Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
Chemotherapy resistance of breast cancer poses a great challenge to the survival of patients. During breast cancer treatment, the development of intrinsic and acquired drug resistance tends to further induce adverse prognosis, such as metastasis. In recent years, the progress of research on cytokine...
Autores principales: | Chen, Weilong, Qin, Yuanyuan, Liu, Suling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119679/ https://www.ncbi.nlm.nih.gov/pubmed/30175384 http://dx.doi.org/10.1186/s40169-018-0205-6 |
Ejemplares similares
-
Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer
por: Wang, Cenzhu, et al.
Publicado: (2021) -
Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2022) -
Targeting NFκB signaling in GD2(+) BCSCs
por: Nguyen, Khoa, et al.
Publicado: (2017) -
Targeting Breast Cancer Stem Cells
por: Zhang, Lu, et al.
Publicado: (2023) -
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
por: Samuel, Samson Mathews, et al.
Publicado: (2020)